Cardiac Surgery
In an observational analysis of adults (aged 18-50 years) who have undergone aortic valve surgery, the Ross procedure was associated with better outcomes compared to prosthetic aortic valve replacement.
22 Feb, 2022 | 08:44h | UTCPropensity-Matched Comparison of the Ross Procedure and Prosthetic Aortic Valve Replacement in Adults – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Cohort Study: Association between handover of anesthesiology care and 1-year mortality among adults undergoing cardiac surgery.
16 Feb, 2022 | 08:20h | UTCInvited Commentary: Safety of Complete Anesthesia Handovers in the Cardiac Surgical Patient – JAMA Network Open
Commentary on Twitter
Anesthesia handover was associated with a higher risk of death at 30 days and 1-year and increased resource utilization. Strategies are needed to balance provider well-being and adverse impact of physician fatigue with unintended info loss during handover. https://t.co/yqQEwH0ksx
— JAMA Network Open (@JAMANetworkOpen) February 11, 2022
Cardiac surgery-associated acute kidney injury: incidence, epidemiology, clinical outcomes, and economic impact.
28 Jan, 2022 | 08:04h | UTC
Guidelines on the management of Type B aortic dissection.
26 Jan, 2022 | 02:06h | UTCNews Release: New practice guideline addresses diagnosis, treatment of type B aortic dissection – The Society of Thoracic Surgeons
Retrospective cohort study: Occurrence and predictors of pericardial effusion requiring invasive treatment following heart valve surgery.
24 Jan, 2022 | 08:10h | UTC
The year in cardiovascular medicine 2021: valvular heart disease.
13 Jan, 2022 | 08:34h | UTCThe year in cardiovascular medicine 2021: valvular heart disease – European Heart Journal
In 1st, US surgeons transplant pig heart into human patient.
11 Jan, 2022 | 02:34h | UTCIn 1st, US surgeons transplant pig heart into human patient – Associated Press
Registry Study: Determinants of outcomes following surgery for type A acute aortic dissection.
11 Jan, 2022 | 02:12h | UTC
Commentary on Twitter
Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit https://t.co/nKH9jJLjdp #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/5C5jGd4DV6
— European Society of Cardiology Journals (@ESC_Journals) September 30, 2021
Guideline: Prevention, diagnosis, and management of post-surgical mediastinitis in adults.
17 Dec, 2021 | 08:41h | UTC
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.
10 Dec, 2021 | 10:11h | UTCGuideline Hub: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Executive Summary: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
News release: Coronary Revascularization the Focus of New ACC/AHA Clinical Guideline
ACC/AHA Slide Set: 2021 ACC/AHA/SCAI Guidelines for Coronary Artery Revascularization
Top Things to Know: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Key Perspectives: ACC/AHA/SCAI Coronary Revascularization Guideline
Commentary on Twitter
🆕 ACC/@American_Heart/@SCAI #ClinicalGuidelines for Coronary Artery Revascularization released today. This guideline provides a patient-centric approach to guide clinicians in the treatment of patients undergoing #Revasc. Access the full guideline here: https://t.co/rr6TI5kFzI pic.twitter.com/f3xdTFAaUi
— American College of Cardiology (@ACCinTouch) December 9, 2021
Life expectancy after surgical aortic valve replacement.
10 Dec, 2021 | 10:06h | UTC
NICE Guideline | Heart valve disease presenting in adults: investigation and management.
18 Nov, 2021 | 08:44h | UTCRelated Guidelines:
2020 ACC/AHA Guideline for the management of patients with valvular heart disease
#AHA21 – M-A: Among patients with left main coronary disease, there was no statistically significant difference in 5-year all-cause death between percutaneous coronary intervention with drug-eluting stents vs. coronary artery bypass grafting.
16 Nov, 2021 | 08:31h | UTCPercutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis – The Lancet (free registration required)
Commentary: No Mortality Difference Between PCI and CABG for Left Main PCI: Meta-analysis – TCTMD
Review and algorithm: Dysphagia aortica.
16 Nov, 2021 | 08:19h | UTCDysphagia aortica – European Surgery
#AHA21 – RCT: Concomitant tricuspid repair in patients undergoing surgery for degenerative mitral regurgitation reduced tricuspid regurgitation progression but increased the need for permanent pacemaker implantation.
14 Nov, 2021 | 20:00h | UTCConcomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years – TCTMD
CTCR-MVS: Concomitant Tricuspid Repair in Patients With MR – American College of Cardiology
#AHA21 – RCT: In asymptomatic patients with severe aortic stenosis, early surgery improved outcomes compared to conservative treatment.
14 Nov, 2021 | 20:01h | UTCAortic Valve ReplAcemenT versus Conservative Treatment in Asymptomatic SeveRe Aortic Stenosis: The AVATAR Trial – Circulation (free for a limited period)
News release: Surgery to replace heart valve beneficial even with no symptoms of severe aortic stenosis – American Heart Association
Commentaries:
AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients – TCTMD
Related study: #AHA19 – Randomized Trial: Early Surgery Improves Outcomes in Asymptomatic Patients with Very Severe Aortic Stenosis
Commentary on Twitter
#OriginalResearch SimPub#AHA21: The #AVATAR RCT of 157 patients with asymptomatic severe #AS and normal LVEF found that early #SAVR associated w/reduced composite outcome of death, MI, stroke or HF hospitalization compared to mgmt. https://t.co/SdMiWHOPnp #AHAJournals pic.twitter.com/jCcWVZfzse
— Circulation (@CircAHA) November 13, 2021
#AHA21 – RCT: Among patients undergoing cardiac surgery, routine posterior left pericardiotomy can prevent postoperative atrial fibrillation.
14 Nov, 2021 | 19:53h | UTCPosterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial – The Lancet (free registration required)
Commentaries:
A short cut to prevent postoperative atrial fibrillation – The Lancet (free registration required)
#AHA21 – [Not published Yet] A small, randomized study showed stopping ticagrelor only 2-3 days before bypass surgery may be safe.
14 Nov, 2021 | 19:56h | UTCCommentary: RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor – TCTMD
Lessons from a Superb Clinical Trial – commentary on a recent randomized trial testing left atrial appendage occlusion during cardiac surgery to prevent stroke.
9 Nov, 2021 | 01:08h | UTCLessons from a Superb Clinical Trial – by Dr. John Mandrola
RCT: In patients with three-vessel coronary artery disease, an FFR–guided PCI strategy was NOT noninferior to coronary bypass surgery – The 1-year incidence of the composite primary end point (death, myocardial infarction, or stroke) was 7.3% in the FFR-guided PCI group and 5.2% in the CABG group.
5 Nov, 2021 | 09:49h | UTCCommentaries:
FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD – TCTMD
FAME 3: FFR-Guided PCI vs. CABG in Patients With Three-Vessel CAD – American College of Cardiology
Commentary on Twitter
In this trial, patients with three-vessel coronary artery disease, PCI guided by assessment of fractional flow reserve was not noninferior to CABG with respect to the composite end point of death, myocardial infarction, stroke, or repeat revascularization. https://t.co/uYZGZWub0T pic.twitter.com/zsghs2SlsA
— NEJM (@NEJM) November 4, 2021
Guidelines for anesthesiologists on patient blood management in cardiac surgery.
17 Oct, 2021 | 21:22h | UTC
Commentary on Twitter
Please check out editorial on patient #blood management in #cardiacsurgery, a collaboration between Society of Thoracic Surgeons, Society of Cardiovascular Anestheisologists and SABM, AmSECT. https://t.co/HHA8SjxNot pic.twitter.com/DAj2TrGYC3
— Jiapeng Huang (@jiapenghuang) September 24, 2021
Varied extent of mitral annular disjunction among cases with different phenotypes of mitral valve prolapse.
7 Oct, 2021 | 10:12h | UTC
Commentary on Twitter
Varied Extent of #MAD Among Cases With Different Phenotypes of #Mitral Valve #Prolapse ➡️ 3D #YesCCT ➡️ https://t.co/7q4GqIAZQd @JACCJournals @UCLA @argulian @purviparwani @MinnowWalsh @BakhshiHooman @MrinShettyMD @mividovich #JACCCaseReports @gina_lundberg @chiarabd @EstefaniaOS pic.twitter.com/6gVnaBg3cb
— Julia Grapsa MD, PhD (@JGrapsa) August 18, 2021
Review: Coronary artery anomalies.
28 Sep, 2021 | 09:02h | UTCCoronary Artery Anomalies – Circulation (free for a limited period)
Commentary on Twitter
#InDepth Review highlighting current diagnostic and therapeutic approaches to Coronary Artery Anomalies https://t.co/TB5HWvgHiE #AHAJournals pic.twitter.com/OaCGUNSPfW
— Circulation (@CircAHA) September 23, 2021
#ESCCongress – 2021 ESC/EACTS Guidelines for the management of valvular heart disease – in the new guidelines, more patients are eligible for surgical and transcatheter interventions, based not only on symptoms but also on imaging criteria.
29 Aug, 2021 | 18:23h | UTCNews release: European valvular heart disease Guidelines published today – European Society of Cardiology
Summary: 2021 ESC/EACTS Valvular Heart Disease Guidelines: Key Points – American College of Cardiology
Commentary: Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. – MedPage Today (free registration required)
“In line with recent U.S. recommendations, the newest European guidelines favor a wider pool of patients eligible for surgical and transcatheter interventions for valvular heart disease.” (from MedPage Today)
Commentaries on Twitter
#ESCCongress new VHD guidelines out ➡️https://t.co/fFkuivAM9E
➡️SAVR in low risk pts <75yrs old
➡️ TAVR in pts >75
➡️ Role of heart team emphasised
➡️ NEW! intervention to be considered with asymptomatic AS with lv <55% IIa@HanCardiomd @Hragy @aayshacader @DrMarthaGulati #TAVR pic.twitter.com/JV1zocQJaK— Mamas A. Mamas (@mmamas1973) August 28, 2021
🆕Guidelines for the management of valvular heart disease #ESCCongress @escardio @secardiologia @EACTS
📂 https://t.co/3FCS8YYKIr @mmamas1973 @shci_sec pic.twitter.com/wxuf3AjVaE
— Alfonso Valle (@ValleAlfonso) August 28, 2021
Optimal antithrombotic therapy for valve prostheses from the 2021 #ESC Guidelines for the management of VHD #ESCCongress @escardio https://t.co/AmQJkZBMoo pic.twitter.com/WK2wQSSlhL
— Dr Roxana Mehran (@Drroxmehran) August 28, 2021
(thread – click for more)
Have there been changes in when to intervene with the new 2021 ESC/EACTS guidelines for the management of valvular heart disease?
Yes, and in general the bar for intervention is now lower
Thread follows…#ESCCongress
1/n pic.twitter.com/iLN9cLCtLj
— Sarah Hudson (@sarahhudsonuk) August 28, 2021
Donor drug use is not associated with worse recipient survival in heart transplantation – “Increasing use of such donors may help alleviate the chronic donor shortage.”
30 Jul, 2021 | 11:39h | UTCIntoxicated Donors and Heart Transplant Outcomes: Long-Term Safety – Circulation: Heart Failure
Commentary: Donor Drug Use Not Tied to Survival for Heart Transplant Recipients – HealthDay
Related study: National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts? – Circulation: Heart Failure


